Valeo Financial Advisors, LLC Axogen, Inc. Transaction History

Valeo Financial Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 22, 2021	SELL	$17.8 - $23.5 $117,604 - $155,264	-6,607 Closed	0 $0
Q3 2019 Oct 15, 2019	BUY	$12.09 - $20.46 $12,090 - $20,460	1,000 Added 17.83%	6,607 $82,000
Q1 2019 Apr 12, 2019	SELL	$14.62 - $22.13 $14,620 - $22,130	-1,000 Reduced 15.14%	5,607 $118,000
Q2 2018 Aug 14, 2018	SELL	$36.15 - $52.5 $216,900 - $315,000	-6,000 Reduced 47.59%	6,607 $244,000
Q3 2017 Nov 15, 2017	BUY	$14.65 - $19.35 $14,650 - $19,350	1,000 Added 8.62%	12,607 $244,000
Q3 2017 Nov 14, 2017	BUY	$14.65 - $19.35 $170,042 - $224,595	11,607	11,607 $225,000

163

36.6M

230K

400

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $623M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

Get notified when there are updates to the investment portfolio of Valeo Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Valeo Financial Advisors, LLC with notifications on news.